Treatment options for hepatocellular cancer apart from surgical resection are limited because of the drug-refractory nature of this disease. Little is known about the role of somatostatin-receptors in hepatocellular cancer, and somatostatin analogs have not been investigated for treatment of this malignancy. We present the case of a 68-yr-old male, who was successfully treated with the long-acting somatostatin analog lanreotide.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1572-0241.1999.00821.x | DOI Listing |
Publication Analysis
Top Keywords
long-acting somatostatin
8
somatostatin analog
8
analog lanreotide
8
hepatocellular cancer
8
successful treatment
4
treatment advanced
4
advanced hepatocellular
4
hepatocellular carcinoma
4
carcinoma long-acting
4
lanreotide treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!